SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001615774-17-002784
Filing Date
2017-05-30
Accepted
2017-05-30 16:07:39
Documents
22
Period of Report
2017-05-30
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K s106386_8k.htm 8-K 16668
2 EXHIBIT 99.01 s106386_ex99-01.htm EX-99.01 24320
3 EXHIBIT 99.02 s106386_ex99-02.htm EX-99.02 14377
4 GRAPHIC image_001.jpg GRAPHIC 122250
5 GRAPHIC image_002.jpg GRAPHIC 250179
6 GRAPHIC image_003.jpg GRAPHIC 230700
7 GRAPHIC image_004.jpg GRAPHIC 210265
8 GRAPHIC image_005.jpg GRAPHIC 203594
9 GRAPHIC image_006.jpg GRAPHIC 263066
10 GRAPHIC image_007.jpg GRAPHIC 160734
11 GRAPHIC image_008.jpg GRAPHIC 227741
12 GRAPHIC image_009.jpg GRAPHIC 246199
13 GRAPHIC image_010.jpg GRAPHIC 154402
14 GRAPHIC image_011.jpg GRAPHIC 200889
15 GRAPHIC image_012.jpg GRAPHIC 219346
16 GRAPHIC image_013.jpg GRAPHIC 220236
17 GRAPHIC image_014.jpg GRAPHIC 211949
18 GRAPHIC image_015.jpg GRAPHIC 204747
19 GRAPHIC image_016.jpg GRAPHIC 213995
20 GRAPHIC image_017.jpg GRAPHIC 232027
21 GRAPHIC image_018.jpg GRAPHIC 61110
22 GRAPHIC pg1img1_ex99-02.jpg GRAPHIC 11557
  Complete submission text file 0001615774-17-002784.txt   5079110
Mailing Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36019 | Film No.: 17877468
SIC: 2834 Pharmaceutical Preparations